Literature DB >> 26773389

Molecular pharming - VLPs made in plants.

Johanna Marsian1, George P Lomonossoff2.   

Abstract

Plant-based expression offers a safe, inexpensive and potentially limitless way to produce therapeutics in a quick and flexible manner. Plants require only simple inorganic nutrients, water, carbon dioxide and sunlight for efficient growth. Virus-like particles (VLPs) are convincing look-alikes of viruses but without carrying infectious genomic material. However, they can still elicit a very potent immune response which makes them ideal vaccine candidates. In this review the different methods of plant expression are described together with the most recent developments in the field of transiently-expressed plant-made VLPs.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26773389     DOI: 10.1016/j.copbio.2015.12.007

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  42 in total

1.  Physalis Mottle Virus-Like Particles as Nanocarriers for Imaging Reagents and Drugs.

Authors:  Hema Masarapu; Bindi K Patel; Paul L Chariou; He Hu; Neetu M Gulati; Bradley L Carpenter; Reza A Ghiladi; Sourabh Shukla; Nicole F Steinmetz
Journal:  Biomacromolecules       Date:  2017-11-16       Impact factor: 6.988

2.  Plant-based chimeric HPV-virus-like particles bearing amyloid-β epitopes elicit antibodies able to recognize amyloid plaques in APP-tg mouse and Alzheimer's disease brains.

Authors:  R Gonzalez-Castro; G Acero Galindo; Y García Salcedo; L Uribe Campero; V Vazquez Perez; M Carrillo-Tripp; G Gevorkian; M A Gomez Lim
Journal:  Inflammopharmacology       Date:  2017-11-01       Impact factor: 4.473

3.  High accumulation in tobacco seeds of hemagglutinin antigen from avian (H5N1) influenza.

Authors:  Yanaysi Ceballo; Kenia Tiel; Alina López; Gleysin Cabrera; Marlene Pérez; Osmany Ramos; Yamilka Rosabal; Carlos Montero; Rima Menassa; Ann Depicker; Abel Hernández
Journal:  Transgenic Res       Date:  2017-10-06       Impact factor: 2.788

Review 4.  Harnessing plant metabolic diversity.

Authors:  Charlie Owen; Nicola J Patron; Ancheng Huang; Anne Osbourn
Journal:  Curr Opin Chem Biol       Date:  2017-05-17       Impact factor: 8.972

Review 5.  The Sweet Side of Plant-Specialized Metabolism.

Authors:  Thomas Louveau; Anne Osbourn
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-12-02       Impact factor: 9.708

Review 6.  A guide to the contained use of plant virus infectious clones.

Authors:  Helen C Brewer; Diane L Hird; Andy M Bailey; Susan E Seal; Gary D Foster
Journal:  Plant Biotechnol J       Date:  2018-02-06       Impact factor: 9.803

7.  A translational synthetic biology platform for rapid access to gram-scale quantities of novel drug-like molecules.

Authors:  James Reed; Michael J Stephenson; Karel Miettinen; Bastiaan Brouwer; Aymeric Leveau; Paul Brett; Rebecca J M Goss; Alain Goossens; Maria A O'Connell; Anne Osbourn
Journal:  Metab Eng       Date:  2017-07-04       Impact factor: 8.829

Review 8.  Synthetic plant virology for nanobiotechnology and nanomedicine.

Authors:  John F C Steele; Hadrien Peyret; Keith Saunders; Roger Castells-Graells; Johanna Marsian; Yulia Meshcheriakova; George P Lomonossoff
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-01-11

Review 9.  The Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis B.

Authors:  Young Hee Joung; Se Hee Park; Ki-Beom Moon; Jae-Heung Jeon; Hye-Sun Cho; Hyun-Soon Kim
Journal:  Int J Mol Sci       Date:  2016-10-13       Impact factor: 5.923

Review 10.  Novel roles for well-known players: from tobacco mosaic virus pests to enzymatically active assemblies.

Authors:  Claudia Koch; Fabian J Eber; Carlos Azucena; Alexander Förste; Stefan Walheim; Thomas Schimmel; Alexander M Bittner; Holger Jeske; Hartmut Gliemann; Sabine Eiben; Fania C Geiger; Christina Wege
Journal:  Beilstein J Nanotechnol       Date:  2016-04-25       Impact factor: 3.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.